Procedures & recovery · patient guide

Radical nephrectomy or partial nephrectomy: how the choice is made

The choice between partial nephrectomy, which removes the tumour and leaves the rest of the kidney, and radical nephrectomy, which removes the whole kidney, is a surgical judgement. It rests on tumour size, position and appearance on imaging, how much kidney function you have and will keep, and what the operation must achieve. No scan result alone decides it, and the operating team makes the final call.

Go to the practical guidance ↓
AI illustration: A kidney anatomical model, stethoscope, clipboard, and pen on a desk in a medical office with a plant in the background.
AI-generated illustration for care planning; not a photograph of a real patient, clinician or hospital, and not a diagnostic image.
In this guide

What actually separates the two operations

Partial nephrectomy removes the tumour with a margin of normal tissue and preserves the remaining kidney. Radical nephrectomy removes the entire kidney, and depending on the tumour it may also involve surrounding fat, the adrenal gland or nearby structures. The two are not simply small and large versions of the same operation: they differ in what is removed, what kidney function remains, and what risks the patient carries afterwards.

For a patient, the practical question is not which operation sounds more modern. It is which operation gives the necessary cancer control while leaving enough kidney function and an acceptable risk profile. Those two goals can pull in different directions, and the surgeon has to weigh them for your specific tumour and your specific body.

The decision is also not made once and fixed forever. Imaging reviewed at one hospital may be interpreted differently at another, and a plan discussed before surgery can change if the operative findings differ from what the scans suggested. Ask the team how firm the plan is and what would make them change it.

The tumour features that drive the recommendation

Tumour size is a starting point, not a verdict. Larger tumours are more often treated with radical nephrectomy, but size alone does not rule out a partial operation, and a small tumour in an awkward position can still be difficult to remove partially.

Position matters greatly. A tumour at the outer edge of the kidney is generally easier to remove with clear margins than one deep in the central part of the kidney, close to the collecting system or major blood vessels. The surgeon also considers how much of the kidney would remain after the tumour is removed, and whether the remaining tissue could keep working.

Imaging appearance influences suspicion as well. Contrast-enhanced CT or MRI helps the team judge whether a mass looks like a kidney cancer, how it relates to nearby structures, and whether there are signs of local spread or tumour thrombus in the renal vein. Some masses turn out not to be cancer at all, which is one reason the plan is confirmed with the patient rather than announced from a scan report alone.

The number of kidneys, whether there is a hereditary kidney cancer syndrome, and whether there are tumours in both kidneys all change the calculation. In those situations preserving kidney tissue becomes a stronger priority, and the team may consider a partial operation, or a strategy that treats one side and then the other, depending on the clinical picture.

Kidney function and the rest of your health

Kidney function is central to the choice. A partial nephrectomy leaves more functioning kidney tissue, which matters most for people whose kidney function is already reduced, who have a single kidney, or who have conditions such as diabetes or long-standing hypertension that put the kidneys under strain. For those patients, preserving tissue can be a major reason to favour a partial operation if the tumour allows it.

The team also looks at the whole patient: age, fitness for anaesthesia, other medical conditions, bleeding risk and current medicines. A partial nephrectomy can be a more demanding operation with a higher chance of bleeding or urine leakage from the operated area, and that trade-off has to be weighed against the longer-term value of keeping kidney tissue. These are clinical judgements, and the balance differs from one patient to the next.

Ask directly what your kidney function is now, what it is expected to be after each option, and how that expectation was reached. If you already see a kidney specialist, ask whether that clinician should be involved in the decision before surgery.

What the surgeon needs from your records

A useful surgical opinion depends on the actual images, not only a written report. Bring the CT or MRI on disc or through a link the hospital can open, together with the radiology reports. If a biopsy has been done, include the pathology report and, where possible, the slides or blocks so the receiving hospital can review them if it wishes.

Blood tests showing kidney function, a recent full blood count and liver function results help the team assess fitness and plan. A list of current medicines, including blood thinners, and any allergies should be included. Previous kidney surgery, stone disease or a known single kidney should be stated clearly, because each changes the operative plan.

Do not send passport numbers, payment details or a complete lifetime archive at first contact. A short summary of the diagnosis, the main question and the key reports is enough to start. The hospital will say what else it needs. If a record is missing, say so rather than waiting until everything is perfect; the team can tell you whether the gap matters for the decision.

Questions that make the choice clearer

The most useful consultation is one where you leave knowing why one operation is preferred. Ask what the imaging shows about the tumour's size, position and relationship to the collecting system and vessels. Ask whether a partial nephrectomy is technically feasible, and if not, what specifically makes it unsafe or unlikely to clear the tumour.

Ask what the plan is if the tumour turns out to be more extensive than expected during surgery, and whether you will be asked to consent to that possibility in advance. Ask about the risks the team considers most relevant for you, including bleeding, urine leakage, loss of kidney function and the chance that further treatment may be needed. Ask what follow-up surveillance is proposed and who will arrange it.

It is reasonable to ask how many of these operations the surgical team performs and how it audits its results, but treat the answer as information to discuss, not as a guarantee. A responsible team can explain its reasoning and its limits. You are entitled to a second surgical opinion, and seeking one does not commit you to treatment at either hospital.

Planning care in China and the next step

For international patients, the practical sequence is usually a records-based review first, then a decision about travelling for an in-person assessment. A remote review can discuss the imaging and the likely options, but it cannot replace the operating surgeon's examination and final judgement. Hospital acceptance and the final operation are decided by the treating hospital and its clinicians.

ChinaSpecialistCare can help you organise a specialist appointment or a records-based opinion with a relevant hospital team, and can coordinate interpretation and practical arrangements if you travel. Hospital consultation, tests, treatment and room charges are paid to the hospital; our coordination fees are separate. Ask for a written explanation of what any quote covers before you commit.

Start with a free initial enquiry: send a short summary of the diagnosis, your main question and the key imaging and pathology reports. The team will identify what is missing and suggest the relevant next step. You do not need to buy a proxy consultation to make that first contact, and an enquiry does not promise acceptance or a particular operation.

Related treatment reference

Sources & scope of this guide

References and official service information relevant to this guide.

  1. radical nephrectomy
  2. Related treatment reference
  3. NICE guideline NG151: Renal and ureteric cancer – recognition and referral
  4. European Association of Urology guidelines on renal cell carcinoma
  5. American Urological Association: Renal mass and localized renal cancer guideline
  6. National Cancer Institute: Renal cell carcinoma treatment (PDQ)

This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.